| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |